General Information of Drug (ID: DMLZ5TQ)

Drug Name
Hexamethylene amiloride Drug Info
Synonyms
5-(N,N-Hexamethylene)amiloride; 5-HMA; BIDD; BSPBio_003443; C12H18ClN7O; DivK1c_006875; HMA; HMA-5; Hexamethyleneamiloride; KBioGR_001206; KBioSS_002076; Lopac-A-9561; Lopac0_000104; MLS002153208; N,N-HEXAMETHYLENEAMILORIDE; SPECTRUM1504215; SpecPlus_000779; Spectrum2_001669; Spectrum3_001662; Spectrum4_000623; Spectrum5_001388; Spectrum_001596
Indication
Disease Entry ICD 11 Status REF
Severe acute respiratory syndrome (SARS) 1D65 Preclinical [1]
Therapeutic Class
Antiviral Agents
Cross-matching ID
PubChem CID
1794
ChEBI ID
CHEBI:76400
CAS Number
CAS 1428-95-1
TTD Drug ID
DMLZ5TQ

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
SARS-CoV envelope small membrane protein (E) TTL3H2W VEMP_CVHSA Inhibitor [1]

References

1 Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov. 2016 May;15(5):327-47.